Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.905 USD | -1.30% | -5.25% | -19.36% |
May. 09 | Transcript : Xeris Biopharma Holdings, Inc., Q1 2024 Earnings Call, May 09, 2024 | |
May. 09 | Earnings Flash (XERS) XERIS BIOPHARMA HOLDINGS Reports Q1 Revenue $40.6M, vs. Street Est of $41.8M | MT |
Evolution of the average Target Price on Xeris Biopharma Holdings, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Xeris Biopharma Holdings, Inc.
Oppenheimer | |
Craig-Hallum | |
SVB Securities LLC | |
Jefferies & Co. | |
Mizuho Securities | |
SVB Leerink | |
HC Wainwright |
EPS Revisions
- Stock Market
- Equities
- XERS Stock
- Consensus Xeris Biopharma Holdings, Inc.